Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 5 hours agoBut longer-term sales are expected to be below 2024 estimates. It will be key to watch how the...
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Yahoo Finance via AOL· 2 days agoSince the multibillion-dollar COVID windfall, investors have been anxious about the near-term...
'Highest concentrations we've ever measured': COVID is teeming in SF wastewater
San Francisco Chronicle· 2 days agoIf you or any of your friends have gotten sick with COVID-19 recently, you’re not the only ones:...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 hours agoBoth measures beat expectations. Earnings turned around from a year-earlier loss, while sales...
Gavi to boost access to life-saving human rabies vaccines in over 50 countries: Gavi, WHO and UAR
World Health Organization· 10 hours agoGavi, the Vaccine Alliance, in collaboration with partners, is announcing support for human rabies ...
Are presidents good role models for vaccination? DRC study shows only if they're trusted and people...
Medical Xpress· 1 day agoOn the one hand, this can be explained by challenges with the supply of vaccines and the reduced...
Would vaccines stop bird flu, now jumping from poultry to dairy cows? It's complicated.
The Des Moines Register via Yahoo News· 4 days agoIt said last week it will begin testing dairy farms near sites of poultry outbreaks, in addition to...
Here are 7 things Arizonans need to know about the new KP.3 variant of COVID-19
The Arizona Republic· 2 days agoA new variant of COVID-19 called KP.3 is on the rise in the U.S. and has been detected in Arizona....
Why 4 new bird flu developments have experts worried about the virus
Business Insider via Yahoo News· 1 day agoFurthermore, scientists now have proven mRNA vaccine technology at the ready. Vaccines that use...
Moderna says combination flu, COVID shot succeeds in study
BioPharma Dive via Yahoo Finance· 4 days agoMichael Yee, an analyst at Jefferies, wrote in a note to clients that, while the company’s “pipeline...